NCT02175719View on ClinicalTrials.gov

Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

April 16, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Cervical Dystonia
Trial Locations (2)

Unknown

Osaka

Tokyo

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT02175719 - Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A | Biotech Hunter | Biotech Hunter